Vergent Bioscience, Inc.

New Filing

CIK: 0001741495·Biotechnology·DELAWARE·Filed: Jun 1, 2018

Total Offering

$8,680,613

Amount Sold

$8,680,613

Investors

14

First Sale

May 18, 2018

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2013
Non-Accredited Investors: No

Related Persons

Name	Role
John Santini	Related Person
Jeffrey Julkowski	Related Person
Samuel Dean Banks	Related Person
Douglas Kohrs	Related Person
Raymond Wong	Related Person
Jeffrey Yurecko	Related Person

Company

Vergent Bioscience, Inc.

420 N 5TH ST

MINNEAPOLIS, MN, 55401

612-928-6515

SEC Filing

0001741495-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.